A Development and Validation of RP-HPLC Method for the Determination of Degradation Impurities in Anagrelide Dosage Form

References

• Hussar, D.A. (1998). New drugs of 1997. Journal of the American Pharmaceutical Association. 38: 155-198.
   Google Scholar
• Tomer, A. (2002). Effects of Anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia. Blood. 99(5): 1602-1609. doi: https://doi.org/10.1182/blood.V99.5.1602
   PubMed Web of Science ®Google Scholar
• Andrew, I., Schafer, M.D. (2004). Thrombocytosis. The New England Journal of Medicine. 350: 1211-1219. doi: https://doi.org/10.1056/NEJMra035363
   PubMed Web of Science ®Google Scholar
• Birgegard, G., Bjorkholm, M., Kutti, J., Larfars, G., Lofvenberg, E., Markeva, B., Merup, M., Palmblad, J., Mauritzson, N., Westin, J., Samuelsson, J. (2004). Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. Haematologica. 89(5): 520-7.
   PubMed Web of Science ®Google Scholar
• Pujeri, S., Addagadde, M., Jaldappagari, S. (2012). Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride. Scientia Pharmaceutica. 80: 567-579. doi: https://doi.org/10.3797/scipharm.1112-22
   PubMedGoogle Scholar
• Venugopal, V., Ramu, G., Malleswara Rao, N.N.V., Rambabu, C. (2012). New RP-HPLC method development for the estimation of anti-thrombocythemia agent anagrelide in pure and pharmaceutical formulations. Der Pharma Chemica. 4(4): 1716-1722.
   Google Scholar
• Sujatha, K., Palavan, C., Seshagiri Rao, J.V.L.N. (2013). A validated RP-HPLC method for the estimation of Anagrelide in capsule dosage forms. International Journal of Pharmaceutical Sciences and Research. 4(10): 3920-3924.
   Google Scholar
• Kerns, E.H., Russel, J.W., Gallo, D.G. (1987). Determination of Anagrelide in plasma by capillary gas chromatography-mass spectrometry. Journal of Chromatography B. 416(2): 357–64. doi: https://doi.org/10.1016/0378-4347(87)80520-0
   Google Scholar
• Zhu, Z., Gonthier, R., Neirinck, L. (2005). High-performance liquid chromatography- mass spectrometry method for determination of Anagrelide in human plasma. Journal of Chromatography B. 822: 238-243. doi: https://doi.org/10.1016/j.jchromb.2005.06.021
   PubMed Web of Science ®Google Scholar
• Dongala, T., Katari, N.K., Ettaboina, S.K., Krishnan, A., Murtaza, M.T., Kamal, D. (2021). In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19. Frontiers in Molecular Biosciences. 7: 1-6. doi: https://doi.org/10.3389/fmolb.2020.613393
   Web of Science ®Google Scholar
• Dongala, T., Katari, N.K., Ettaboina, S.K., Krishnan, A. (2021). In-vitro Dissolution profile at different biological pH conditions of Hydroxy Chloroquine Sulfate Tablets is available for the treatment of COVID 19. Frontiers in Molecular Biosciences. 7: 441. doi: https://doi.org/10.3389/fmolb.2020.613393
   Web of Science ®Google Scholar
• Snyder, L., Kirkland, J., Glajch, J. (1997). Practical HPLC Method Development, A Wiley Inter science publication.
   Google Scholar
• Shukla, R., Singh, R., Arfi, S., Tiwari, R., Tiwari, G., Pranaywal. (2016). Degradation and its forced effect: A trenchant tool for stability studies. International Journal of Pharmacy & Life Sciences. 7(4): 4987-4995.
   Google Scholar
• Singh, R., Rehman, Z. (2012). Current trends in forced degradation study for pharmaceutical product development. Journal of Pharmaceutical Education and Researach. 3: 54-63.
   Google Scholar
• Lakka, N.S., Kuppan. C., Kona, S.S., Yarra, R. (2020). Separation and Characterization of New Forced Degradation Products of Dasatinib in Tablet Dosage Formulation Using LC-MS and Stability-Indicating HPLC Methods. Chromatographia. 83: 947-962. doi: https://doi.org/10.1007/s10337-020-03920-0
   Web of Science ®Google Scholar
• Dongala, T., Katari, N.K., Rao, K.L.N., Palakurthi A.K., Marriseti V.M. (2020). Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach. Chromatographia. 83(10): 1269-1281. doi: https://doi.org/10.1007/s10337-020-03945-5
   Web of Science ®Google Scholar
• Prakash, L., Malipeddi, H., Venkata Subbaiah, B., Lakka, N.S. (2015). Impurity Profiling and a Stability-Indicating UPLC Method Development and Validation for the Estimation of Related Impurities of Halobetasol Propionate in Halobetasol Propionate 0.05% (w/w) Cream. Journal of Chromatographic Science. 53(1): 112-121. doi: https://doi.org/10.1093/chromsci/bmu027
   PubMed Web of Science ®Google Scholar
• Dongala, T., Katari, N.K., Marisetti, V.M., Jonnalagadda, S.B. (2021). Quantitative estimation of Fulvestrant injection 505(j) composition and impurities profile by capillary gas chromatography and HPLC-PDA techniques. Journal of the Iranian Chemical Society. 18: 1443-1454. doi: https://doi.org/10.1007/s13738-020-02126-3
   Web of Science ®Google Scholar
• Riddhiben, M.P., Piyushbhai, M.P., Natubhai, M.P. (2011). Stability indicating HPLC method development-a review. International Research Journal of Pharmacy. 2: 79-87.
   Google Scholar
• Velusamy, B.S., Konduru, N., Gundla, R., Dongala, T., Katari, N.K. (2020). A simple high-performance liquid chromatography method development for Carbidopa and Levodopa impurities: Evaluation of risk assessment before method validation by Quality by Design approach. Separation Science Plus. 3(11-12): 530-539. doi: https://doi.org/10.1002/sscp.202000029
   Web of Science ®Google Scholar
• Dongala, T., Katari, N.K., Palakurthi, A.K. and Jonnalagadda, S.B. (2019). Stability indicating HPLC method for simultaneous quantification of 14 impurities in excedrin tablet formulations and identification of new impurity by LC-MS in accelerated stability studies. Biomedical Chromatography. 33(10): e4608. doi: https://doi.org/10.1002/bmc.4608
   PubMed Web of Science ®Google Scholar
• Konduru, N., Gundla, R., Katari, N.K., Paidikondala, K., Annem, S.R., Jagadabi, V. (2020). Development and validation of a stability-indicating method for ibrutinib: Identification and separation of degradation products, known and genotoxic impurities using RP-HPLC/PDA and QDa Mass detectors. Analytical Chemistry Letters. 10(1): 113-136. doi: https://doi.org/10.1080/22297928.2019.1673814
   Google Scholar
• Subramanian, V.B., Katari, N.K., Dongala, T., Jonnalagadda, S.B. (2020). Stability- indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach. Biomedical Chromatography. 34(1): e4827. doi: https://doi.org/10.1002/bmc.4719
   PubMed Web of Science ®Google Scholar
• ICH Topic Q2 (R1). Validation of Analytical Procedures: Text and Methodology, 1996. CPMP/ ICH/381/95.
   Google Scholar
• ICH-Guideline Q2A(R1). Validation of Analytical Procedures Text and methodology, 2005.
   Google Scholar
• Guidance for Industry, ICH-Q2B. Validation of Analytical Procedures: Methodology. Food and Drug Administration; Rockville, MD, 1997.
   Google Scholar